Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,628.41
    -1,652.68 (-3.29%)
     
  • CMC Crypto 200

    1,261.77
    -96.24 (-7.09%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Hemato-Oncology Testing Market Trajectory & Analytics Report 2021

Dublin, July 21, 2021 (GLOBE NEWSWIRE) -- The "Hemato Oncology Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Hemato-Oncology Testing Market to Reach $5.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Hemato-Oncology Testing estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$5.4 Billion by 2027, growing at a CAGR of 13.5% over the period 2020-2027.

Services, one of the segments analyzed in the report, is projected to record 13.3% CAGR and reach US$3.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Assay Kits segment is readjusted to a revised 13.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $603 Million, While China is Forecast to Grow at 17.6% CAGR

The Hemato-Oncology Testing market in the U.S. is estimated at US$603 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 17.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.6% and 11.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS(Total 36 Featured):

  • Abbott Laboratories

  • Adaptive Biotechnologies

  • Archerdx, Inc.

  • Arup Laboratories, Inc.

  • Asuragen, Inc.

  • Bio-Rad Laboratories, Inc.

  • F. Hoffman-La Roche Ltd.

  • Illumina, Inc.

  • Invivoscribe, Inc.

  • Molecularmd (Subsidiary of Icon PLC)

  • Qiagen N.V.

  • Sanofi SA

  • Thermo Fisher Scientific, Inc.

ADVERTISEMENT


3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UNITED KINGDOM

  • SPAIN

  • RUSSIA

  • REST OF EUROPE

  • ASIA-PACIFIC

  • AUSTRALIA

  • INDIA

  • SOUTH KOREA

  • REST OF ASIA-PACIFIC

  • LATIN AMERICA

  • ARGENTINA

  • BRAZIL

  • MEXICO

  • REST OF LATIN AMERICA

  • MIDDLE EAST

  • IRAN

  • ISRAEL

  • SAUDI ARABIA

  • UNITED ARAB EMIRATES

  • REST OF MIDDLE EAST

  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 36

For more information about this report visit https://www.researchandmarkets.com/r/1m9jrv

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900